igeahub.com
Seattle Genetics grabs tumor drug of Immunomedics in $2B deal - IgeaHub
February 10, 2017 Seat­tle Ge­net­ics has become the new flag car­rier for the solid tumor drug IMMU-132 of Im­munomedics. In order to claim global